Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany

Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany

Abstract Background Overuse of short-acting beta-2 agonists (SABA), which do not treat the underlying inflammation of asthma, is linked to poor clinical outcomes such as increased exacerbation risk. This study, as part of the SABINA program, estimated the prevalence of SABA overuse and associated va...

Full description

Bibliographic Details
Main Authors: Heinrich Worth, Carl-Peter Criée, Claus F. Vogelmeier, Peter Kardos, Eva-Maria Becker, Karel Kostev, Ingo Mokros, Andrea Schneider
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Respiratory Research
Subjects:
Asthma
Short-acting beta agonists
Overuse
GINA
Risk factors
Germany
Online Access:https://doi.org/10.1186/s12931-021-01701-3

Internet

https://doi.org/10.1186/s12931-021-01701-3

Similar Items